Top

13-02-2017 | Glioblastoma multiforme | Article

Life beyond a diagnosis of glioblastoma: a systematic review of the literature

Journal: Journal of Cancer Survivorship

Authors: L Gately, SA McLachlan, A Dowling, J Philip

Abstract

Background

The median survival of glioblastoma is 12–14 months with less than 10% of patients surviving at least 2 years from diagnosis. Patients diagnosed with glioblastoma face poor prognosis, significant symptom burden, and high care needs. The aim of this study is to undertake a literature review to document the issues encountered by long-term survivors of glioblastoma, a small but important subset of patients.

Methods

MEDLINE, PsychInfo, and EMBASE were searched with core concepts: (1) glioblastoma, (2) survivor, and (3) terms pertaining to survivorship issues. A thematic analysis was undertaken of the three included studies.

Results

Long-term survivors of glioblastoma encounter neurologic deficits, impairment in cognition, psychological distress, reduced social function, and future uncertainty. These issues result in the inability to return to work and financial difficulties. Independence in activities of daily living, working memory, and overall quality of life appears to be preserved.

Conclusions

Long-term survivors of glioblastoma continue to have significant symptom burden and care needs. There is currently a paucity of literature surrounding this topic. Further research is required to accurately describe these issues in order for improved supportive care to be implemented in the community and the outpatient setting.

Implications for Cancer Survivors

Understanding the issues faced by long-term survivor of glioblastoma will provide insight into the care needs of patients as well as support networks required for patients and their carers.

Dobes M, Khurana V, Shadbolt B, et al. Increasing incidence of glioblastoma multiforme and meningioma, and decreasing incidence of schwannoma (2000-2008): findings of a multicentre Australian study. Surg Neurol Int. 2011;2:176.CrossRefPubMedPubMedCentral

Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459–66.CrossRefPubMed

Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–96.CrossRefPubMed

Schmidinger M, Linzmayer L, Becherer A, et al. Psychometric- and quality-of-life assessment in long-term glioblastoma survivors. J Neuro-Oncol. 2003;63(1):55–61.CrossRef

Steinbach JP, Blaicher HP, Herrlinger U, et al. Surviving glioblastoma for more than 5 years: the patient’s perspective. Neurology. 2006;66:239–42.CrossRefPubMed

Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro-Oncology. 2013;15(Suppl 2):ii1–ii56.CrossRefPubMedPubMedCentral

Krex D, Klink B, Hartmann C et al. Long-term survival with glioblastoma multiforme. First published online: 4 September 2007;2596–2606. doi:10.1093/brain/awm204.

Sacko A, Hou MM, Temgoua M, et al. Evolution of the Karnosky Performance Status throughout life in glioblastoma patients. J Neuro-Oncol. 2015;122(3):567–73.CrossRef

Giovagnoli AR, Silvani A, Colombo E, et al. Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry. 2005;76:562–8.CrossRefPubMedPubMedCentral

10.

Meyers C, Boake C. Neurobehavioral disorders experienced by brain tumor patients: rehabilitation strategies. Cancer Bull. 1993;45:362–4.

11.

Sizoo E, Dirven L, Reijneveld J, et al. Measuring health-related quality of life in high-grade glioma patients at the end of life using a proxy-reported retrospective questionnaire. J Neuroonc. 2014;116(2):283–90.CrossRef

12.

Smoll NR, Schaller K, Gautschi OP. Long-term survival of patients with glioblastoma multiforme (GBM). J Clin Neurosci. 2013;20(5):670–5.CrossRefPubMed

13.

Hottinger A, Yoon H, DeAngelis L, et al. Neurological outcome of long-term glioblastoma survivors. J Neuro-Oncol. 2009;95:301–5.CrossRef

14.

Flechl B, Ackerl M, Sax C, et al. Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors. J Neuro-Oncol. 2012;109:331–9.CrossRef

15.

Forst DA, Nahed BV, Loeffler JS, Batchelor TT. Low-grade gliomas. Oncologist. 2014;19(4):403–13.CrossRefPubMedPubMedCentral

16.

Douw L, Klein M, Fagel SS, et al. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol. 2009;8(9):810–8.CrossRefPubMed

17.

Ford E, Catt S, Chalmers A, et al. Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro-Oncology. 2012;14(4):392–404.CrossRefPubMedPubMedCentral

18.

Boele FW, Douw L, Reijneveld JC, et al. Health-related quality of life in stable, long-term survivors of low-grade glioma. JCO. 2015;33(9):1023–9.CrossRef

19.

Kiebert GM, Curran D, Aaronson NK, et al. Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomized phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group. Eur J Cancer. 1998;34(12):1902–9.CrossRefPubMed